Please assess the completion status of the following clinical trial:

Trial Title: Innovative Interventions for Smoking Cessation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* a) Smoking at least 10 cigarettes daily for the past year;~* b) In good physical health;~* c) No contraindications for medicinal nicotine; and~* d) Stable, good mental health.~Exclusion Criteria:~* a) Subjects must not be using other tobacco or nicotine products.~* b) Female subjects cannot be pregnant or nursing and must be using appropriate birth control.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- VLNC Cigarette (Type: ACTIVE_COMPARATOR): Very Low Nicotine Content Cigarette. Dosage: 0.05 mg to 0.09 mg nicotine yield cigarette; Frequency: Daily; Duration: 6 weeks.
- Nicotine Patch (Type: ACTIVE_COMPARATOR): 21 mg nicotine patch. Dosage: 21 mg; Frequency: Daily; Duration: 6 weeks.
- VLNC Cigarette plus Nicotine Patch (Type: EXPERIMENTAL): Very Low Nicotine Content Cigarette plus 21 mg Nicotine Patch. Patch Dosage: 21 mg; Cigarette Dosasge: 0.05 to 0.09 mg nicotine yield; Frequency: Daily; Duration: 6 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).